Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1991 1
1992 1
1993 4
1994 1
1996 1
1997 3
1998 1
1999 6
2000 2
2001 6
2002 1
2003 2
2004 2
2005 2
2006 3
2007 2
2008 6
2009 3
2010 5
2011 2
2012 9
2013 5
2014 8
2015 5
2016 5
2017 3
2018 2
2019 3
2020 5
2021 3
2022 7
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Results by year

Filters applied: . Clear all
Page 1
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial.
Cremolini C, Antoniotti C, Rossini D, Lonardi S, Loupakis F, Pietrantonio F, Bordonaro R, Latiano TP, Tamburini E, Santini D, Passardi A, Marmorino F, Grande R, Aprile G, Zaniboni A, Murgioni S, Granetto C, Buonadonna A, Moretto R, Corallo S, Cordio S, Antonuzzo L, Tomasello G, Masi G, Ronzoni M, Di Donato S, Carlomagno C, Clavarezza M, Ritorto G, Mambrini A, Roselli M, Cupini S, Mammoliti S, Fenocchio E, Corgna E, Zagonel V, Fontanini G, Ugolini C, Boni L, Falcone A; GONO Foundation Investigators. Cremolini C, et al. Lancet Oncol. 2020 Apr;21(4):497-507. doi: 10.1016/S1470-2045(19)30862-9. Epub 2020 Mar 9. Lancet Oncol. 2020. PMID: 32164906 Free article. Clinical Trial.
Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial.
Del Mastro L, Poggio F, Blondeaux E, De Placido S, Giuliano M, Forestieri V, De Laurentiis M, Gravina A, Bisagni G, Rimanti A, Turletti A, Nisticò C, Vaccaro A, Cognetti F, Fabi A, Gasparro S, Garrone O, Alicicco MG, Urracci Y, Mansutti M, Poletti P, Correale P, Bighin C, Puglisi F, Montemurro F, Colantuoni G, Lambertini M, Boni L; Gruppo Italiano Mammella Investigators. Del Mastro L, et al. Lancet Oncol. 2022 Dec;23(12):1571-1582. doi: 10.1016/S1470-2045(22)00632-5. Epub 2022 Nov 10. Lancet Oncol. 2022. PMID: 36370716 Clinical Trial.
Dengue outbreaks: unpredictable incidence time series.
Gabriel AFB, Alencar AP, Miraglia SGEK. Gabriel AFB, et al. Among authors: miraglia sgek. Epidemiol Infect. 2019 Jan;147:e116. doi: 10.1017/S0950268819000311. Epidemiol Infect. 2019. PMID: 30869035 Free PMC article. English.
Role of stenting in gastrointestinal benign and malignant diseases.
Mangiavillano B, Pagano N, Arena M, Miraglia S, Consolo P, Iabichino G, Virgilio C, Luigiano C. Mangiavillano B, et al. Among authors: miraglia s. World J Gastrointest Endosc. 2015 May 16;7(5):460-80. doi: 10.4253/wjge.v7.i5.460. World J Gastrointest Endosc. 2015. PMID: 25992186 Free PMC article. Review.
Liver steatosis in celiac disease: the open door.
Abenavoli L, Luigiano C, Larussa T, Milic N, De Lorenzo A, Stelitano L, Morace C, Consolo P, Miraglia S, Fagoonee S, Virgilio C, Luzza F, Pellicano R. Abenavoli L, et al. Among authors: miraglia s. Minerva Gastroenterol Dietol. 2013 Mar;59(1):89-95. Minerva Gastroenterol Dietol. 2013. PMID: 23478246 Review.
Health impact assessment of air pollution in Lisbon, Portugal.
Abe KC, Rodrigues MA, Miraglia SGEK. Abe KC, et al. Among authors: miraglia sgek. J Air Waste Manag Assoc. 2022 Nov;72(11):1307-1315. doi: 10.1080/10962247.2022.2118192. Epub 2022 Sep 27. J Air Waste Manag Assoc. 2022. PMID: 36048722
106 results